NCT04563390 Effectiveness of a Projection-based Augmented Reality Exposure System in Treating Cockroach Phobia.
| NCT ID | NCT04563390 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universitat Jaume I |
| Condition | Specific Phobia |
| Study Type | INTERVENTIONAL |
| Enrollment | 96 participants |
| Start Date | 2020-11-01 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 96 participants in total. It began in 2020-11-01 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The main aim of this study is to validate and test the clinical effectiveness of the projection-based augmented reality system in cockroach phobia exposure therapy through an RCT that includes three conditions: (i) projection-based augmented reality therapy, (ii) usual treatment (in vivo exposure), (iii) waiting list control. In addition, it is intended to analyze the potential of the eye-tracking technology as a tool for evaluating the clinical effectiveness in cockroach phobia treatment.
Eligibility Criteria
Inclusion Criteria: * Being at least 18 years old * Meeting DSM-5 diagnostic criteria for SP (animal subtype) to cockroaches * Having a minimum of six-month duration of the phobia * Sign an informed consent * Presenting a score of at least 4 on the fear and avoidance scales of the diagnostic interview applied Exclusion Criteria: * Presence of another severe mental disorder that requires immediate attention * Having current alcohol or drug dependence or abuse, psychosis or severe organic illness * Currently being treated in a similar treatment program * Being capable of inserting their hands in a plastic container with a cockroach (during the behavioral test) * Receiving other psychological treatment during the study for cockroach phobia * Start receiving pharmacological treatment during the study (or in case of being already taking them, change the drug or dose)
Contact & Investigator
Soledad Quero, Psychology
PRINCIPAL INVESTIGATOR
Universitat Jaume I
Frequently Asked Questions
Who can join the NCT04563390 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Specific Phobia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04563390 currently recruiting?
Yes, NCT04563390 is actively recruiting participants. Contact the research team at squero@uji.es for enrollment information.
Where is the NCT04563390 trial being conducted?
This trial is being conducted at Castellon, Spain.
Who is sponsoring the NCT04563390 clinical trial?
NCT04563390 is sponsored by Universitat Jaume I. The principal investigator is Soledad Quero, Psychology at Universitat Jaume I. The trial plans to enroll 96 participants.